Jill Weisenbach

481 citations
13 papers · 370 indexed · h-index 6
Topics
Toxin Mechanisms and Immunotoxins (7 papers)Inflammasome and immune disorders (5 papers)Peptidase Inhibition and Analysis (4 papers)

In The Last Decade

Jill Weisenbach

13 papers receiving 363 citations

Peers

Jill Weisenbach
Comparison fields: 5 of 39
  • Immunology 238
  • Oncology 183
  • Molecular Biology 165
  • Pathology and Forensic Medicine 73
  • Genetics 32
Replace D M Grote with:
D M Grote United States
Athalia R. Pyzer United States
Sylvia Snauwaert Belgium
Hsu-Ping Kuo United States
Philip McCoy United States
Eve Marie Neidhardt France
Yasunori Kogure Japan
Christophe Le Clorennec France
Ricardo Garcı́a-Muñoz Spain
Ombretta Rosso Italy
Jill Weisenbach relative to D M Grote United States D M Grote's profile →
Citations per field
00.5×1.5×
D M Grote · 1×
Citations per year

Countries citing papers authored by Jill Weisenbach

Since Specialization
Citations

This map shows the geographic impact of Jill Weisenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Weisenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Weisenbach more than expected).

Fields of papers citing papers by Jill Weisenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Weisenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Weisenbach. The network helps show where Jill Weisenbach may publish in the future.

Co-authorship network of co-authors of Jill Weisenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Weisenbach. A scholar is included among the top collaborators of Jill Weisenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Weisenbach. Jill Weisenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 13
2 2
3 3
4 29
5 1
6 3
7 2
8 94
9 83
10 126
11 4
12 1
13 9

About Jill Weisenbach

Jill Weisenbach is a scholar working on Immunology, Hematology and Pathology and Forensic Medicine, having authored 13 papers that have together received 370 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Inflammasome and immune disorders (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Immunology (238 citations), Oncology (183 citations) and Pathology and Forensic Medicine (73 citations). Jill Weisenbach has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Michael J. Robertson, Kevin M. Koch, Theodore F. Logan, Linda M. Thurmond, Lyndon C. Kirby, Mohammed M. Dar, Steven J. Kathman, William N. Bell, John M. Kirkwood and Coreen Oei. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026